Large-scale testing (Phase 3)WithdrawnNCT07223502
What this trial is testing
A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients With Hypertension and Chronic Kidney Disease
Who this might be right for
Hypertension (HTN)
Sarfez Pharmaceuticals, Inc.